Pharmaceutical Commerce - March/April 2012

The leading chain pharmacy steps up its role as healthcare provider and partner to pharma

Good design of vaults and cages for DEA-regulated materials calls for meeting regulatory requirements while accommodating operational practices

'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials

FDA's draft documents on biosimilar regulation move the prospect one step closer

As FDA makes progress on an active surveillance system, drug manufacturers and third-party drug safety vendors navigate their own set of challenges

Tompkins International's annual preview of key pharma supply chain issues

Begin thinking of your business as a 'disease' company vs. a 'drug' company

Pharmaceutical Commerce sat down with Chris Smith, president and COO; here's what he had to say.

National organization proposes a draft standard; will hold workship in May

Buys marketing rights to networks of independent pharmacies for C$920 million